Treatment
-
Treating Breast Cancer in Men
Hormone therapy may lengthen life in men with hormone-related breast cancer, but this treatment is prescribed less frequently for men than for women.
by Marilyn Fenichel
-
Getting a Read on Cancer
Cancer patients are increasingly receiving treatments guided by the molecular characteristics of their cancer cells. But patients may have unequal access to testing and targeted therapies.
by Kate Yandell
-
Forward Look
A Matter of AgeCell and molecular biologist Ashani Weeraratna discusses how older patients respond to immunotherapy.
by Sue Rochman
-
Forward Look
Treating Head and Neck Skin CancersA study suggests high-risk patients do not need chemotherapy.
by Stephen Ornes
-
Forward Look
Breaking Down Breakthrough Cancer TherapiesDrugs approved through this pathway may have limited evidence.
by Lindsey Konkel
-
Tomorrow’s Trials
New tools are being integrated into the research process to ease patients' access to clinical trials and improve their experience.
by Bradley Jones
-
Forward Look
What’s Next? Winter 2018/2019Off-the-shelf equivalents to CAR-T cell therapy are emerging.
by Bradley Jones
-
From the Editor-in-Chief
Improving Health After TreatmentThe U.S. health care system must adapt to the needs of cancer survivors.
by William G. Nelson, MD, PhD
-
2018 SABCS: Choosing the Right Treatment
Studies presented at the 2018 San Antonio Breast Cancer Symposium investigate when patients with early-stage breast cancer or precancerous breast conditions benefit from receiving less intense treatment.
by Kate Yandell
-
Treating Cancer Based on Its Genetics, Not Its Location
Medical oncologist and sarcoma specialist George D. Demetri explains the significance of the recent approval of the oral drug Vitrakvi based on tumor genetics.
by Anna Azvolinsky